Cargando…

Deficiency of AXL in Bone Marrow-Derived Cells Does Not Affect Advanced Atherosclerotic Lesion Progression

AXL, a member of the TAM (Tyro3, Axl, MerTK) family of receptors, plays important roles in cell survival, clearance of dead cells (efferocytosis), and suppression of inflammation, which are processes that critically influence atherosclerosis progression. Whereas MerTK deficiency promotes defective e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subramanian, Manikandan, Proto, Jonathan D., Matsushima, Glenn K., Tabas, Ira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153620/ https://www.ncbi.nlm.nih.gov/pubmed/27958361 http://dx.doi.org/10.1038/srep39111

Ejemplares similares

Orp8 Deficiency in Bone Marrow-Derived Cells Reduces Atherosclerotic Lesion Progression in LDL Receptor Knockout Mice
por: van Kampen, Erik, et al.
Publicado: (2014)

Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity
por: Subramanian, Manikandan, et al.
Publicado: (2015)

Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis
por: Waterborg, Claire E. J., et al.
Publicado: (2018)

Reduced Size and Macrophage Content of Advanced Atherosclerotic Lesions in Mice with Bone Marrow Specific Deficiency of Alpha 7 Nicotinic Acetylcholine Receptor
por: Lee, Robert H., et al.
Publicado: (2015)

Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
por: Yumoto, Kenji, et al.
Publicado: (2016)

Hypercholesterolemia Impairs Clearance of Neutrophil Extracellular Traps and Promotes Inflammation and Atherosclerotic Plaque Progression
por: Dhawan, Umesh Kumar, et al.
Publicado: (2021)

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
por: Zuo, Pengfei, et al.
Publicado: (2017)

Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progression
por: Theodorou, Kosta, et al.
Publicado: (2017)

How Does Lifestyle Affect Hematopoiesis and the Bone Marrow Microenvironment?
por: Vanhie, James J., et al.
Publicado: (2022)

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

Deletion of Batf3-dependent antigen-presenting cells does not affect atherosclerotic lesion formation in mice
por: Gil-Pulido, Jesus, et al.
Publicado: (2017)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

Macrophage phenotypes and Gas6/Axl signaling in apical lesions
por: Chen, Szu-Yu, et al.
Publicado: (2019)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

The DNA methylation drift of the atherosclerotic aorta increases with lesion progression
por: Valencia-Morales, María del Pilar, et al.
Publicado: (2015)

Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
por: Foks, Amanda C., et al.
Publicado: (2013)

PAC1 deficiency reduces chondrogenesis in atherosclerotic lesions of hypercholesterolemic ApoE-deficient mice
por: Blümm, C., et al.
Publicado: (2023)

Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice
por: Preusch, Michael R, et al.
Publicado: (2015)

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2021)

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance
por: Sinha, Sutapa, et al.
Publicado: (2021)

Does occupational exposure to low-dose ionizing radiation affect bone marrow thrombopoiesis?
por: Sayed, Douaa, et al.
Publicado: (2011)

Does Needle Design Affect the Regenerative Potential of Bone Marrow Aspirate? An In Vitro Study
por: Feddahi, Nadia, et al.
Publicado: (2021)

Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
por: He, Lirui, et al.
Publicado: (2020)

Soluble AXL as a marker of disease progression and survival in melanoma
por: Flem-Karlsen, Karine, et al.
Publicado: (2020)

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
por: Sang, Yun Beom, et al.
Publicado: (2022)

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2018)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Bone marrow lesions: etiology and pathogenesis at the hip
por: Munsch, Maria A, et al.
Publicado: (2020)

Animal Models of Bone Marrow Lesions in Osteoarthritis
por: Bowen, Andrew, et al.
Publicado: (2022)

Biochemical markers of bone turnover and their association with bone marrow lesions
por: Hunter, David J, et al.
Publicado: (2008)

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model
por: Jia, Chenglin, et al.
Publicado: (2014)

Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice
por: Okamoto, Ryoko, et al.
Publicado: (2014)

Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient Mice
por: Grievink, Hendrika W., et al.
Publicado: (2021)

Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice
por: Bot, Martine, et al.
Publicado: (2013)

Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021)

Deficient Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplantation
por: Glenn, Jared W., et al.
Publicado: (2016)

Blockade of the BLT1-LTB(4) axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr(−/−) mice
por: Depuydt, Marie A. C., et al.
Publicado: (2022)

Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling
por: Tanaka, Mai, et al.
Publicado: (2021)

Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
por: von Mässenhausen, Anne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f0e268kvt51ma0nksrvr2iti3q